85 Trending Stocks

Fri, Jan 15, 2021

Catalent Inc

CTLT 115.50
0.26 (0.2%)

Open: 115.01 High: 115.74 Low: 113.77

9 x 115.50 = 1039.5
x $115.50 =

NYSE: CTLT $19 Billion Large-Cap. S&P 500. Health Care Sector. Drug Manufacturers Industry. 5 Year Return 383%. 1 Year Return 88%. 2021 YTD Return 11%. Since Earnings 30%.

ST

External Links

Charts

image
image

52WL $31.04

The 52 Week Low is $31.04 set on Wed, Mar 18, 2020.

52WH $117.61

The 52 Week High is $117.61 set on Tue, Jan 12, 2021.

ATH $117.61

The All-Time High is $117.61 set on Tue, Jan 12, 2021.

52 Week Range

$31.04
$117.61
Mar 18, 2020
Jan 12, 2021

Earnings

0.08

Earnings Per Share

43.53

Price To Earnings Ratio


Q2 Earnings for Apr, May & Jun

Mon, Aug 31, 2020

Since Q2 Earnings Report

CTLT 31.8%


Q3 Earnings for Jul, Aug & Sep

Tue, Nov 3, 2020

Since Q3 Earnings Report

CTLT 30.5%

Dividends

0.00

Dividend Yield

0.00

Dividend Rate

--

Ex-Dividend Date

--

Dividend Payment Date

--

Dividend Frequency

0

Dividend History

Profile

Catalent Inc trades on the NYSE. CTLT's market cap is 19.0 Billion.

Catalent Inc is a specialty and generic drug manufacturing company. The company focuses on advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. The vast majority of Catalent's sales are generated in the United States, followed by Europe and the rest of the world. Most of the company's sales are derived from branded drug products. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Website

Related Channels

Free Channels & more...

For Starters

Account Channels

Track your portfolio and more.